Crossmark

Endothelial progenitor cells as the target for cardiovascular disease prediction, personalized prevention, and treatments: progressing beyond the state-of-the-art

Crossref DOI link: https://doi.org/10.1007/s13167-020-00223-0

Published Online: 2020-09-21

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kou, Fang

Zhu, Chao

Wan, Hongjiang

Xue, Fulong

Wang, Jianfeng

Xiang, Lijie

Li, Jingan https://orcid.org/0000-0002-8311-1739
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2017YFB0702500, 2018YFC1106703 and 2016YFC1102403)

Top Doctor Program of Zhengzhou University (32210475)
License Information

Text and Data Mining valid from 2020-09-21

Version of Record valid from 2020-09-21
More Information

Article History

Received: 5 July 2020

Accepted: 11 September 2020

First Online: 21 September 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below